Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort studyXue Bai, Zhong‐Yi Dong, Si-Cong Ma et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 63
Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolismXue Bai, Daidi Fan|Journal of Advanced Research|2024Cited by 59
CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapyXue Bai, Zhong‐Yi Dong|Nature Communications|2023Cited by 58